期刊
INFECTION GENETICS AND EVOLUTION
卷 92, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.meegid.2021.104869
关键词
SARS-CoV-2; COVID-19; Variants; Lineages; VACCINES; Diagnostic tests
资金
- Italian Ministry of Health
- Fondazione Cariplo, Italy (grant CORONA) [2020-1353]
- Department of Biotechnology, Govt. of India
- MICIN (Spanish Government) [BFU2017-89594-R]
- Japan Agency for Medical Research and Development, AMED [JP20fk0108103]
Three new viral variants associated with extensive transmission have been identified during the COVID-19 pandemic, originating from the UK, South Africa, and Brazil. These variants, designated as variants of concern (VOCs), exhibit a high number of amino acid substitutions, raising concerns about potential changes in the evolution of the virus. Strengthened genomic surveillance, especially following vaccination campaigns, is essential to monitor the spread and impact of these VOCs.
The COVID-19 pandemic was officially declared on March 11th, 2020. Since the very beginning, the spread of the virus has been tracked nearly in real-time by worldwide genome sequencing efforts. As of March 2021, more than 830,000 SARS-CoV-2 genomes have been uploaded in GISAID and this wealth of data allowed researchers to study the evolution of SARS-CoV-2 during this first pandemic year. In parallel, nomenclatures systems, often with poor consistency among each other, have been developed to designate emerging viral lineages. Despite general fears that the virus might mutate to become more virulent or transmissible, SARS-CoV-2 genetic diversity has remained relatively low during the first similar to 8 months of sustained human-to-human transmission. At the end of 2020/beginning of 2021, though, some alarming events started to raise concerns of possible changes in the evolutionary trajectory of the virus. Specifically, three new viral variants associated with extensive transmission have been described as variants of concern (VOC). These variants were first reported in the UK (B.1.1.7), South Africa (B.1.351) and Brazil (P.1). Their designation as VOCs was determined by an increase of local cases and by the high number of amino acid substitutions harboured by these lineages. This latter feature is reminiscent of viral sequences isolated from immunocompromised patients with long-term infection, suggesting a possible causal link. Here we review the events that led to the identification of these lineages, as well as emerging data concerning their possible implications for viral phenotypes, reinfection risk, vaccine efficiency and epidemic potential. Most of the available evidence is, to date, provisional, but still represents a starting point to uncover the potential threat posed by the VOCs. We also stress that genomic surveillance must be strengthened, especially in the wake of the vaccination campaigns.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据